DecisionPoint Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Buy
451
+445
+7,417% +$177K 0.03% 72
2026
Q2
$2.17K Sell
6
-5
-45% -$1.71K ﹤0.01% 312
2026
Q1
$3.87K Sell
11
-12
-52% -$4.28K ﹤0.01% 238
2025
Q4
$7.53K Buy
23
+12
+109% +$3.81K ﹤0.01% 217
2025
Q3
$3.28K Hold
11
– – ﹤0.01% 200
2025
Q2
$3.2K Buy
+11
New +$3.12K ﹤0.01% 202
2023
Q4
– Sell
-8
Closed -$2.15K – 215
2023
Q3
$2.15K Buy
+8
New +$2K ﹤0.01% 192

Other funds holding AMGN

DecisionPoint Financial's AMGN Position: Q3 2026 in Review

DecisionPoint Financial increased its Amgen (AMGN) stake by 7,417% in Q3 2026, buying an estimated $177K and bringing the position to 451 shares worth $184K. The position accounts for 0.03% of the portfolio, ranked #72.

DecisionPoint Financial first reported a position in AMGN in Q3 2023 and has held it in 7 quarters since. 1,235 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • DecisionPoint Financial held 451 shares of Amgen worth $184K as of Q3 2026.
  • DecisionPoint Financial bought 445 Amgen shares in Q3 2026, an estimated $177K.
  • Amgen made up 0.03% of DecisionPoint Financial's portfolio in Q3 2026, its #72 holding.
  • DecisionPoint Financial first reported a position in Amgen in Q3 2023 and has held it in 7 quarters since.
  • 1,235 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.